Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

By sjmartinez • December 4, 2023

Flack JM, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Adler SG, Fried L, Jamerson K, Toto R, Brinker M, Farjat AE, Kolkhof P, Lawatscheck R, Joseph A, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials. Kidney Med. 2023 Sep 28;5(12):100730. doi: 10.1016/j.xkme.2023.100730. PMID: 38046911; PMCID: PMC10692708.

Tags: Cardiorenal, Chronic kidney disease, Clinical Trial, Finerenone, Harbor UCLA, Nephrology, Publications, Race, Type 2 diabetes

Aortic arch calcification in relation to cigarette smoking: results from the multi-ethnic study of atherosclerosis (MESA)

Ansari S, Trujillo R, McClelland RL, Budoff MJ. Aortic arch calcification in relation to cigarette smoking: results from the multi-ethnic study of atherosclerosis (MESA). Int[...]

Transcatheter Structural Heart Interventions in Women

Chung J, Yang K, Nozadze N, Kukarni A, Ashwath M, Bui Q, Co-Vu J, Jone PN, Lyubarova R, Andrade-Bucknor S. Transcatheter Structural Heart Interventions in[...]

Possible long COVID biomarker: identification of SARC-CoV-2 related protein(s) in Serum Extracellular Vesicles

Abbasi A, Sharma R, Hansen N, Pirrotte P, Stringer WW. Possible long COVID biomarker: identification of SARC-CoV-2 related protein(s) in Serum Extracellular Vesicles. Infection. 2025[...]